Stem cell research conflict bill moves a step closer to ballot
By Knight Ridder,
Knight Ridder
| 05. 19. 2005
A measure to strengthen conflict-of-interest rules on Proposition 71-funded stem cell research cleared a second legislative hurdle Wednesday, even as critics warned it would scare off scientists.
The bill, SCA13, co-authored by Sens. Deborah Ortiz, D-Sacramento, and George Runner, R-Lancaster, passed the Senate committee on elections on a 5-0 vote. It is due to be considered next in the Senate Appropriations Committee on Monday.
The legislation would require the agency set up by Proposition 71, the measure voters approved in the fall to provide $3 billion toward stem cell research, to follow standards recently applied to the National Institutes of Health.
Those rules forbid employees from holding biotech or pharmaceutical stocks. SCA13 would extend the regulations to the California Institute for Regenerative Medicine, the agency overseeing the research, and its advisory groups.
To become law, the constitutional amendment must receive a two-thirds majority from both houses of the Legislature and be passed by the state's voters.
Related Articles
By Carl Zimmer and Marco Hernandez , The New York Times | 07.01.2026
Scientists have long dreamed of discovering the alchemy by which chemicals can be turned into life. On Wednesday, a team at the University of Minnesota announced that it had taken a major step toward that vision.
Blending together dozens of...
By Marisa Flook , BioNews | 06.29.2026
An anti-ageing gene therapy not approved by the US Food and Drug Administration (FDA) is set to be offered by an American company at overseas clinics outside of US jurisdiction.
The treatment, developed by Minicircle from Austin, Texas, uses a...
By Ed Pilkington, The Guardian | 06.12.2026
Desperate US parents paying up to $20,000 a session for a procedure scientists say could be bogus
Autistic children as young as 18 months old are being injected with human stem cells derived from umbilical cords in unapproved, unproven and...
By Tobi Thomas, The Guardian | 06.10.2026
The UK’s stem cell transplant system is potentially putting the lives of blood cancer patients at risk as a result of inadequate infrastructure and a lack of long-term planning, a parliamentary report has found.
A hematopoietic stem cell transplant, often...